CombiGene selects AmbioPharm as peptide CDMO partner for their COZY01 pain project
15 Sep 2023 //
PRESS RELEASE
Roche`s Spark adds epilepsy asset to pipeline with $328M deal
13 Oct 2021 //
FIERCEBIOTECH
Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug
25 Jun 2021 //
CONTRACTPHARMA